|
|
||||||||
Departments of 1 Pediatric Critical Care, 2 Infectious Disease, and 4 Pulmonary Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262; and 3 Cell Therapeutics, Inc., Seattle, Washington 98119
Lisofylline
[1-(5R-hydroxyhexyl)-3,7-dimethylxanthine]
decreases lipid peroxidation in vitro and in vivo suppresses
proinflammatory cytokine expression in models of lung injury due to
sepsis, blood loss, and oxidative damage. In the present experiments,
we used a murine hyperoxia model to examine the effects of lisofylline on the activation of nuclear transcriptional regulatory factors [nuclear factor-
B and cAMP response element binding protein
(CREB)], the expression of proinflammatory cytokines in the
lungs, and the circulating levels of oxidized free fatty acids as well
as on hyperoxia-induced lung injury and mortality. Treatment with lisofylline inhibited hyperoxia-associated increases in tumor necrosis
factor-
, interleukin-1
, and interleukin-6 in the lungs as well as
decreased the levels of hyperoxia-induced serum-oxidized free fatty
acids. Although hyperoxic exposure produced activation of both nuclear
factor-
B and CREB in lung cell populations, only CREB activation was
reduced in the mice treated with lisofylline. Lisofylline diminished
hyperoxia-associated increases in lung wet-to-dry weight ratios and
improved survival in animals exposed to hyperoxia. These results
suggest that lisofylline ameliorates hyperoxia-induced lung
injury and mortality through inhibiting CREB activation, membrane
oxidation, and proinflammatory cytokine expression in the lungs.
cytokine expression; nuclear factor-
B; adenosine
3',5'-cyclic monophosphate response element binding
protein; lipid oxidation
This article has been cited by other articles:
![]() |
H. Pei, J. Gu, P.-R. Thimmalapura, A. Mison, and J. L. Nadler Activation of the 12-lipoxygenase and signal transducer and activator of transcription pathway during neointima formation in a model of the metabolic syndrome Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E92 - E102. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Buckley, L. Barsky, K. Weinberg, and D. Warburton In vivo inosine protects alveolar epithelial type 2 cells against hyperoxia-induced DNA damage through MAP kinase signaling Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L569 - L575. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. D'Angio, M. B. LoMonaco, C. J. Johnston, C. K. Reed, and J. N. Finkelstein Differential roles for NF-{kappa}B in endotoxin and oxygen induction of interleukin-8 in the macrophage Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L30 - L36. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |